Xanthone Derivatives and Their Potential Usage in the Treatment of Telangiectasia and Rosacea

• Published in: Applied sciences Vol. 14; no. 10; p. 4037
• Main Authors: Brezdeń, Katarzyna, Waszkielewicz, Anna M
• Format: Journal Article
• Language: English
• Published: Basel MDPI AG 01.05.2024
• Subjects: Angiogenesis; Antioxidants; Atherosclerosis; Blood vessels; Cancer; Care and treatment; cosmetics; Dermatologic agents; Dermatology; Development and progression; Diabetes; Endothelium; Enzymes; Formulae, receipts, prescriptions; Homeostasis; Hyaluronic acid; Inflammation; Kinases; Molecular weight; Permeability; Physiology; Rosacea; Skin; Skin diseases; Smooth muscle; telangiectasia; Telangiectasis; Thrombosis; Type 2 diabetes; vascular disorders; Vascular endothelial growth factor; Vein & artery diseases; xanthone; Poland
• ISSN: 2076-3417; 2076-3417
• DOI: 10.3390/app14104037

Xanthone derivatives, a class of natural compounds abundantly found in plants such as mangosteen (Garcinia mangostana) and certain herbs, have garnered substantial interest due to their diverse pharmacological properties, including antioxidant, anti-inflammatory, and anti-cancer activities. Recent investigations have unveiled their potential as modulators of enzymatic activity, prompting exploration into their effects on hyaluronidase-mediated hyaluronic acid (HA) degradation, and their effects in topical treatment of telangiectasia and rosacea. Telangiectasia and rosacea are common dermatological conditions characterized by chronic skin inflammation, vascular abnormalities, and visible blood vessels, resulting in significant cosmetic concerns and impaired quality of life for affected individuals. This review aims to provide a comprehensive overview of the current understanding regarding the interplay between the mechanisms of action by which xanthone derivatives exert their therapeutic effects, including the inhibition of pro-inflammatory cytokines, modulation of oxidative stress pathways, and regulation of vascular endothelial growth factors. Furthermore, we will discuss the implications of harnessing xanthone derivatives as therapeutic agents for mitigating vascular dysfunction and its associated pathologies, thereby offering insights into future research directions and therapeutic strategies in the field of vascular biology.